AGP Executive Report
Last update: 3 hours agoRegulatory Integrity: A new report argues the FDA’s user-fee funding and revolving-door ties leave drug oversight vulnerable, while NIH royalties add more pressure on public research priorities. Medicare Costs: Senate Democrats propose a $5,000 annual cap on out-of-pocket spending for traditional Medicare hospital and physician services starting in 2028, echoing ongoing fights over affordability. Medicaid Turbulence: CMS ends a “fast-track” review for some Medicaid waiver renewals, with budget-neutrality rules kicking in from Jan. 1, 2027—raising uncertainty for states and providers. Access to GLP-1s: China will add semaglutide to its essential drug list for public hospitals, aiming to widen availability beyond brand-only access. Clinical Safety & Training: A U.S. survey finds most clinicians support medical cannabis but many lack structured training to use it safely in practice. Public Health & Preparedness: Global health leaders meet at Ichilov Medical Center to train for crisis preparedness, reflecting how hospitals are planning for wars, cyberattacks, and outbreaks. Community Health: Feeding America’s “Food as Medicine” work in Atlanta reports fewer overnight hospitalizations among participants. Drug Misuse Trend: Misuse of ADHD stimulants among young adults drops sharply, linked partly to earlier shortages.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
